CapecitabineChemotherapy, AdjuvantNeoplasm, Residual
Dr. Margaret Block, MD
NPI1184604118PAC ID7911060306
- Medicare services, 2024
- 93,361
- Medicare patients, 2024
- 978
- Part D claims, 2024
- 2,052
- Publications
- 7
- Clinical trials
- 12
- Practice address
- 17201 Wright St, Omaha, NE 68130
- Practice phone
- Call (402) 354-8124
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Oncology Hematology West
Omaha, Nebraska
Find Dr. Block's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Margaret Block is a hematologist and oncologist in Omaha, Nebraska
Dr. Block practices at Oncology Hematology West in Omaha, Nebraska.
Dr. Block's NPI, 1184604118, was assigned on January 17, 2006. Dr. Block graduated from Albany Medical College of Union University in 1976. Dr. Block holds Nebraska license 18002.
NPI and contact details
- NPI
- 1184604118NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7911060306
- NPI enumeration date
- January 17, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (402) 354-8124
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 76
- Medical school graduation
- 1976
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Margaret Block practices at Oncology Hematology West in Omaha, Nebraska
Dr. Block's primary practice is Oncology Hematology West, at 17201 Wright St, Omaha, NE 68130 in Douglas County. The practice phone is (402) 354-8124.
- Oncology Hematology West17201 Wright St, Omaha, NE 68130 · Douglas CountyPhone(402) 354-8124
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Margaret Block is affiliated with 6 sites of care and 1 medical group
Dr. Block's primary practice is Oncology Hematology West in Omaha, Nebraska. Dr. Block is also affiliated with CHI Health Creighton University Medical Center - Bergan Mercy. The medical group on file is Nebraska Cancer Specialists. Dmand AI also links Dr. Block to 4 more hospitals, each named with a free account.
Oncology Hematology WestPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Margaret Block's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Block practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Oncology Hematology West | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Block practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Margaret Block is one of 80 hematologists and oncologists in Nebraska
Hematology and oncology is Dr. Block's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Block is licensed in Nebraska.
Specialties and state licenses
- Hematology and oncology, NebraskaPrimary
Hematologists and oncologists near Dr. Block
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Margaret Block billed Medicare for 93,361 services in 2024
CMS data shows 93,361 Medicare services from Dr. Block across 62 procedure codes in 2024, for 978 Medicare patients. Medicare paid $1,356,325 for them.
Medicare services, 202493,361
Medicare patients978
Paid by Medicare$1.4M
Procedure codes62
Dr. Block's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 106,5802024: 83,27722%
- Lab and pathology
- 2023: 6,3102024: 5,9745%
- Tests and treatments
- 2023: 2,5362024: 1,84627%
- Office and hospital visits
- 2023: 1,7982024: 1,7214%
- Other services
- 2023: 252024: 4281612%
- Surgery
- 2023: 1562024: 11526%
Where Dr. Block's Medicare services took place, 2024
- In an office93,284100%
- In a facility770%
Dr. Block compared with the Nebraska median for hematologists and oncologists, 2024
- Dr. Block
- Nebraska median
- Medicare services
- 93,361vs 1,32270.6 times
- Medicare patients
- 978vs 4082.4 times
- Part D claims
- 1,826vs 5493.3 times
Medians across 79 hematologists and oncologists in Nebraska with Dmand AI profiles that report each measure.
Dr. Block's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Block?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Block and other hematologists and oncologists in Nebraska.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Margaret Block treated 978 Medicare patients in 2024, average age 75
CMS counts 978 Medicare patients who saw Dr. Block in 2024. The largest group is 65 to 74, with 466 patients. 75% of them have cancer, and 71% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Block's median patient age at 70, with 81% women.
Medicare patients, 2024978
Average age75
Average risk score1.55
Also on Medicaid3%
Dr. Block's Medicare patients by age, 2024
Dr. Block's Medicare patients by sex, 2024
- Women78280%
- Men19620%
Chronic conditions among Dr. Block's Medicare patients, 2024
- Cancer75%
- High blood pressure71%
- High cholesterol70%
- Arthritis49%
- Osteoporosis27%
- Chronic kidney disease25%
- Mood disorders24%
- Depression23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Block's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women81%
- Men18%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Margaret Block wrote 2,052 Medicare Part D claims in 2024
In 2024, Dr. Block wrote 2,052 Medicare Part D claims for 346 patients. 87% of them were for generic drugs. CMS names the drug for 1,826 of them, across 37 drugs with 11 or more claims each, at $2,257,741 in total drug cost. In 2023, CMS named 1,688 claims across 29 drugs.
Part D claims, 20242,052
Drugs named by CMS37
Total drug cost$2.3M
Part D patients346
Dr. Block's Part D claims by kind of drug, 2024
- Generic1,775 claims87%
- Brand-name277 claims13%
Dr. Block's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Block's Part D claims, 2024
- Opioids1%12 of 2,052 claims
- Antibiotics3%56 of 2,052 claims
- Antipsychotics, patients 65 and over2%37 of 2,052 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,6882024: 1,8268%
Drugs named by CMS: 37 in 2024, 29 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Margaret Block scored 85 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Block for performance year 2024, reported as part of a group. Dr. Block accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Block's MIPS scores, performance year 2024
- 85of 100Final score
- 89.9of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 54of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Block by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Margaret Block has 7 publications on record
Dmand AI links 7 papers to Dr. Block, published from 2017 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Capecitabine and Platinum. Dr. Block has published most often in J Clin Oncol. Dr. Block's most frequent co-authors are Angela Demichele, MD, Brian Leslie Burnette, MD and Shabana J. Dewani, MD.
Papers7
Years published2017 to 2024
Dr. Block's papers by year, 2017 to 2024
Topics Dr. Block writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Capecitabine
- Platinum
- Triple Negative Breast Neoplasms
Dr. Block's most frequent co-authors
- Angela Demichele, MD4 shared papers
- Brian Leslie Burnette, MD3 shared papers
- Shabana J. Dewani, MD3 shared papers
Recent publications by Dr. Block
Antineoplastic Combined Chemotherapy ProtocolsCapecitabineNeoadjuvant Therapy
See who Dr. Block researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Block works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Margaret Block has worked on 12 clinical trials
Dmand AI links Dr. Block to 12 clinical trials, 4 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Cluster Headache. Eli Lilly and Company sponsors the most, 5. Open Payments lists research payments to Dr. Block that name 3 trials.
Clinical trials with Dr. Block by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Block's trials
- Breast Neoplasms
- Breast Diseases
- Cluster Headache
- Trigeminal Autonomic Cephalalgias
- Neoplasm Metastasis
Investigators on the most trials with Dr. Block
- Jay Christopher Andersen, MD5 shared trials
- Erika P. Hamilton, MD5 shared trials
- Paul D. Richards, MD5 shared trials
Recent clinical trials with Dr. Block
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd (opens in a new tab)
RecruitingPhase 2
Neoplasm MetastasisNeoplastic ProcessesARX788
A Phase 2 Study to Evaluate the Safety and Efficacy of Lerociclib in Participants With Advanced Breast Cancer (opens in a new tab)
TerminatedPhase 2
Lerociclib + Letrozole or Fulvestrant
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer (opens in a new tab)
Active, not recruitingPhase 3
Breast NeoplasmsBreast DiseasesPertuzumabTrastuzumabTucatinib
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer (opens in a new tab)
Active, not recruitingPhase 2
Breast NeoplasmsBreast DiseasesTrastuzumab deruxtecanTucatinib
Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer (opens in a new tab)
CompletedPhase 2
Breast NeoplasmsBreast DiseasesRibociclibAnastrozoleGoserelin
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Margaret Block received $9,300 in industry payments from 2016 to 2025
CMS Open Payments shows 54 general payments to Dr. Block from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 82% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,633. It also lists 5 research payments totaling $437,378 from 2016 to 2024, naming 3 clinical trials.
General payments to Dr. Block by program year, 2016 to 2025
General payments to Dr. Block by kind, 2016 to 2025
$9.3Kin total
- Consulting fees$7,61082%
- Food and beverage$1,56917%
- Education$1211%
Companies that paid Dr. Block the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Margaret Block graduated from Albany Medical College of Union University
Dr. Block graduated from Albany Medical College of Union University in 1976.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Margaret Block's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Margaret Block
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Margaret Block's NPI number?
Dr. Margaret Block's NPI number is 1184604118. It was assigned on January 17, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Margaret Block?
Dr. Margaret Block is a hematologist and oncologist in Omaha, Nebraska. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Margaret Block practice?
Dr. Block practices at 17201 Wright St, Omaha, NE 68130. Dr. Block's primary practice is Oncology Hematology West in Omaha, Nebraska. Dmand AI also links Dr. Block to 4 hospitals.
What is Dr. Margaret Block's office phone number?
The practice phone on file for Dr. Block is (402) 354-8124.
What is Dr. Margaret Block's medical license number?
Dr. Block holds Nebraska license 18002.
Which hospitals is Dr. Margaret Block affiliated with?
Dr. Block is affiliated with CHI Health Creighton University Medical Center - Bergan Mercy. Dmand AI links Dr. Block to 4 more hospitals.
What medical group is Dr. Margaret Block part of?
Dr. Block is linked to Nebraska Cancer Specialists.
Does Dr. Margaret Block accept Medicare?
Yes. CMS data shows Dr. Block billed Medicare for 93,361 services in 2024, and Dr. Block accepts Medicare assignment.
What is Dr. Margaret Block's MIPS score?
Dr. Block's MIPS final score for performance year 2024 is 85 out of 100, reported as part of a group.
How many Medicare patients does Dr. Margaret Block see?
CMS counts 978 Medicare patients who saw Dr. Block in 2024, with an average age of 75.
Show 7 more questionsShow fewer questions
What services does Dr. Margaret Block bill to Medicare?
In 2024, Dr. Block's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J0881) and injected or infused drug (J9271).
Where did Dr. Margaret Block go to medical school?
Dr. Block graduated from Albany Medical College of Union University in 1976.
What drugs does Dr. Margaret Block prescribe most?
In 2024 Medicare Part D data, Dr. Block's most prescribed drugs by claims were Letrozole, Potassium Chloride and Alendronate Sodium.
Has Dr. Margaret Block received payments from drug or device companies?
CMS Open Payments shows $9,300 in general payments to Dr. Block from 21 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Margaret Block been practicing?
Dr. Block graduated from medical school in 1976, 50 years ago.
Does Dr. Margaret Block do research?
Dmand AI links 7 publications to Dr. Block, published from 2017 to 2024. Dr. Block has worked on 12 clinical trials.
Who does Dr. Margaret Block publish with?
Dr. Block's most frequent co-authors are Angela Demichele, MD (4 shared papers), Brian Leslie Burnette, MD (3 shared papers) and Shabana J. Dewani, MD (3 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Nebraska by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card